Upload
Featured Recent Articles Topics Login Upload

Search Results for 'hiv phase'

hiv phase published presentations and documents on DocSlides.

HIV Prevention England Conference
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
The Revolution of mRNA Vaccines: Implications for an HIV Vaccine
The Revolution of mRNA Vaccines: Implications for an HIV Vaccine
by carny
Richard A. . Koup. , MD. Acting Director. Vaccine ...
HIV and AIDS Andrew De
HIV and AIDS Andrew De
by test
S. aro. , EMT-B, BS, . DC. , DICCP, . P. h. C. (h...
Toward Universal HIV Testing:
Toward Universal HIV Testing:
by cheryl-pisano
Is the CDC Recommendation of “Opt-out” Screen...
Regulatory issues in HIV cure Research
Regulatory issues in HIV cure Research
by debby-jeon
HIV Cure Research Training Curriculum. Regulatory...
PrEP –
PrEP –
by cheryl-pisano
New Drugs and Delivery Systems. Roy M. Gulick, MD...
New Prevention Technologies Workshop
New Prevention Technologies Workshop
by sherrill-nordquist
Module 3: Overview of Prevention Research. www.ic...
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
by debby-jeon
Weill Cornell Medicine. New York, New York. Inves...
Long Acting ART for Treatment and
Long Acting ART for Treatment and
by tatyana-admore
PrEP. Anton Pozniak . MD FRCP. Consultant Physici...
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
by trish-goza
Weill Cornell Medicine. New York, New York. Inves...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by conchita-marotz
, . prodrug. of . temsavir. . (attachment inhib...
Rectal Mucosa Ian McGowan MD DPhil FRCP
Rectal Mucosa Ian McGowan MD DPhil FRCP
by marina-yarberry
University of Pittsburgh, PA, USA. 21. st. July,...
Recalibrating the EID Cascade in Zimbabwe
Recalibrating the EID Cascade in Zimbabwe
by mitsue-stanley
True outcomes among a sample of HIV-exposed infan...
Long Acting Injectable Agents for HIV Prevention
Long Acting Injectable Agents for HIV Prevention
by giovanna-bartolotta
Nyaradzo M Mgodi (. MBChB. , . MMed. ). On behalf...
A two-arm (proof of concept) randomised phase II trial Vorinostat plus a prime boost Vaccine
A two-arm (proof of concept) randomised phase II trial Vorinostat plus a prime boost Vaccine
by alexa-scheidler
A-899-0059-12977. Presented by Professor Sarah Fi...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
What’s Next – and When:
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Joseph J. Eron, Jr, MD
Joseph J. Eron, Jr, MD
by karlyn-bohler
Joseph J. Eron, Jr, MD Professor of Medicine and ...
Results of Phase II study of
Results of Phase II study of
by grace3
Durvalumab. in cancer patients with HIV-1 infecti...
Joseph J. Eron, Jr, MD Professor of Medicine and Epidemiology
Joseph J. Eron, Jr, MD Professor of Medicine and Epidemiology
by Hulksmash
The University of North Carolina at Chapel Hill. C...
Immunoglobulin Classes and Acute Phase Proteins In
Immunoglobulin Classes and Acute Phase Proteins In
by murphy
The Breast Milk and Plasma of Nigerian HIV-Infecte...
The Magic of MAPP A Fresh
The Magic of MAPP A Fresh
by pagi
Framework to Guide Comprehensive Planning. New Orl...
New and Investigational ART Drugs and Strategies
New and Investigational ART Drugs and Strategies
by elina
Judith S. Currier, MD, . MSc. Division of Infectio...
Solent Sexual Health Services - Overview
Solent Sexual Health Services - Overview
by jiraiya471
October 2022. Clare Scholfield - Clinical Director...
A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and
A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and
by warlikebikers
IMPAACT . 2001 STUDY . Mhembere T.P. (B. Pharm . (...
ALL, Acute lymphoblastic leukemia;
ALL, Acute lymphoblastic leukemia;
by HappyHippo
BCMA, B-cell maturation antigen; DLBCL, diffuse la...
State of the Field Exploring 2015’s Top Ten List for the HIV Prevention Research Field
State of the Field Exploring 2015’s Top Ten List for the HIV Prevention Research Field
by brooke
Manju Chatani, Stacey Hannah, Mitchell Warren. Thu...
Getting Outside of the Box: Designing and Implementing Inno
Getting Outside of the Box: Designing and Implementing Inno
by lindy-dunigan
Willo Pequegnat, Ph.D., Salix Health Consulting/U...
Phase 2 of new ARVs
Phase 2 of new ARVs
by mitsue-stanley
Fostemsavir. , . prodrug. of . temsavir. . (. a...
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
Roy M. Gulick, MD, MPH Gladys and Roland Harriman Professor of Medicine
by luanne-stotts
Chief, Division of Infectious Diseases. Weill Med...
Project Steering Committee Meeting
Project Steering Committee Meeting
by pamella-moone
Colombo, 2012. RAS/H13: Prevention of transmissio...
Hanneke Schuitemaker VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines
Hanneke Schuitemaker VP, Head Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines
by debby-jeon
Professor in Virology at the Academic Medical Cen...
Tuberculosis Trials Consortium Study 31
Tuberculosis Trials Consortium Study 31
by stefany-barnette
AIDS Clinical Trials Group A5349. Rifapentine-con...
Routine use of point-of-care early infant diagnosis testing in Côte d’Ivoire:
Routine use of point-of-care early infant diagnosis testing in Côte d’Ivoire:
by tatiana-dople
Early lessons learnt. Patricia . Fassinou . Ekou...
Safety , Tolerability, and Pharmacokinetics of Long-Acting Injectable
Safety , Tolerability, and Pharmacokinetics of Long-Acting Injectable
by phoebe-click
Cabotegravir. in Low-Risk . HIV-uninfected . Wom...
C-EDGE Co-Infected: Phase 3 Study of
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
Phase 2 of new ARVs Fostemsavir
Phase 2 of new ARVs Fostemsavir
by sportyinds
, . prodrug. of . temsavir. . (. attachment inhi...
Reaching UNGA HLM on TB targets for ending TB in children and adolesce
Reaching UNGA HLM on TB targets for ending TB in children and adolesce
by garboardcola
First Paediatric Antituberculosis Drug Optimizatio...
SASA Mobilizing Communities to End Violence against Women and HIVAID
SASA Mobilizing Communities to End Violence against Women and HIVAID
by jordyn
(Uganda) SASA! is a programme developed by Raisi...